Overview

Understanding and Treating Traumatic Brain Injury (TBI) Associated Photophobia With Botulinum Toxin Type A (BoNT-A)

Status:
RECRUITING
Trial end date:
2026-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this research is to understand and treat Traumatic Brain Injury (TBI) associated photophobia (light sensitivity) and its impact on visual function.
Phase:
PHASE2
Details
Lead Sponsor:
University of Miami
Collaborator:
United States Department of Defense
Treatments:
incobotulinumtoxinA